The market for biosimilar medicines represents a segment of significant growth within the prescription pharmaceutical arena that is associated with unparalleled development, market access and commercialisation challenges.

In this dynamic environment, Brandwood CKC is uniquely positioned to provide expert advice for both generic and innovator companies on development, registration and commercial strategies. We provide strategic market access and technical consulting services and offer detailed training courses on biosimilar product development and commercialisation.